Stockscreener 앱 받기
35.12
4.86%
-1.32
전일 마감가:
$36.44
열려 있는:
$36.08
하루 거래량:
27,533
Relative Volume:
0.23
시가총액:
$591.81M
수익:
$978.76M
순이익/손실:
$-286.52M
주가수익비율:
-2.0276
EPS:
-17.3212
순현금흐름:
$-31.63M
1주 성능:
-8.06%
1개월 성능:
-9.05%
6개월 성능:
+105.27%
1년 성능:
-42.09%
1일 변동 폭
$34.19
$36.20
1주일 범위
$33.87
$37.77
52주 변동 폭
$11.50
$73.68
Claritev Corp Stock (CTEV) Company Profile
명칭
Claritev Corp
전화
212-780-2000
주소
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, BTSG, TEM, TXG, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
34.92 | 609.77M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
266.40 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
58.77 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.65 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
74.42 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.29 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | Barclays | Overweight |
| 2026-01-12 | 개시 | Guggenheim | Buy |
| 2026-01-09 | 개시 | Wells Fargo | Equal Weight |
| 2025-10-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Neutral |
| 2022-12-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-07-12 | 개시 | Goldman | Neutral |
| 2021-10-04 | 재개 | Citigroup | Buy |
| 2021-04-07 | 개시 | B. Riley Securities | Buy |
| 2021-03-19 | 개시 | Barclays | Equal Weight |
모두보기
Claritev Corp 주식(CTEV)의 최신 뉴스
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks - Yahoo Finance
Bank of America Corp DE Purchases 58,133 Shares of Claritev $CTEV - MarketBeat
Claritev (NYSE:CTEV) CEO Buys 4,500 Shares of Stock - MarketBeat
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com South Africa
Claritev CEO Travis Dalton buys $249,663 in company stock - Investing.com
Travis Dalton Purchases 1,950 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev (CTEV) CEO adds 6,450 shares via spouse IRA - Stock Titan
Claritev (NYSE:CTEV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Claritev Corp (CTEV) Overvalued After 9.4% Rally? GF Value Sa - GuruFocus
CTEV Maintained by Barclays -- Price Target Raised to $40.00 - GuruFocus
Claritev (CTEV) Q2 2026 Earnings Call Transcript - AOL.com
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 8,850 Shares - MarketBeat
Claritev Corp (CTEV) exec sells 8,850 shares, holds 123,723 - Stock Titan
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget
Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget
CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire
Claritev $CTEV Shares Sold by Renaissance Technologies LLC - MarketBeat
Claritev (NYSE:CTEV) Rating Increased to Hold at Zacks Research - MarketBeat
Claritev Corp SEC Filing (Aug 14, 2026) - Stock Titan
Claritev (NYSE:CTEV) Shares Down 5.1%Time to Sell? - MarketBeat
Have Insiders Sold Claritev Shares Recently? - simplywall.st
Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks - Yahoo Finance
Claritev (NYSE:CTEV) Stock Price Up 7.7% Following Analyst Upgrade - MarketBeat
Arini Capital Management Ltd's Claritev Corp(CTEV) Holding History - GuruFocus
Claritev Corp SVP William B. Mintz Sells 8,431 Shares of Class A Stock at $34.24 Each - Kalkine Media
Insider Selling: Claritev (NYSE:CTEV) SVP Sells 8,431 Shares of Stock - MarketBeat
Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing - marketscreener.com
Claritev Corp (CTEV) SVP William Mintz sells 8,431 shares at $34.24 - Stock Titan
CTEV Maintained by Wells Fargo -- Price Target Raised to $30.00 - GuruFocus
Piper Sandler raises Claritev stock price target to $73 on platform strength - Investing.com Nigeria
Claritev (NYSE:CTEV) Price Target Raised to $30.00 - MarketBeat
CTEV: Strong Q2 results, digital transformation, and NSA growth position the business for long-term expansion - TradingView
Canaccord raises Claritev stock price target to $43 on bookings - Investing.com India
Claritev Corp SEC Filing (Aug 10, 2026) - Stock Titan
CTEV Maintains Buy Rating by Citigroup -- Price Target Raised to $45 - GuruFocus
Claritev Analysts Raise Their Forecasts Following Q2 Earnings - Benzinga
Claritev : It’s Time to Take Avoidable Costs Out of Healthcare - marketscreener.com
Canaccord raises Claritev stock price target to $43 on bookings By Investing.com - Investing.com Australia
CTEV Maintains Buy Rating by Canaccord Genuity -- Price Target R - GuruFocus
Claritev (NYSE:CTEV) Price Target Raised to $43.00 - MarketBeat
Citi Maintains Claritev(CTEV.US) With Buy Rating, Raises Target Price to $45 - Moomoo
CLARITEV CORP : CANACCORD GENUITY RAISES TARGET PRICE TO $43 FROM $37 - Bitget
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & G - natlawreview.com
Claritev Corp (CTEV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
5.25%
자본화:
|
볼륨(24시간):